Intl Medication Sys Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INTL MEDICATION SYS, and what generic and branded alternatives to INTL MEDICATION SYS drugs are available?
INTL MEDICATION SYS has ten approved drugs.
Summary for Intl Medication Sys
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 10 |
Drugs and US Patents for Intl Medication Sys
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intl Medication Sys | EPINEPHRINE | epinephrine | SOLUTION;INTRAVENOUS | 211363-001 | Aug 15, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Intl Medication Sys | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 212461-001 | Oct 5, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Intl Medication Sys | MORPHINE SULFATE | morphine sulfate | INJECTABLE;INJECTION | 202861-001 | Apr 29, 2021 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Intl Medication Sys | EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 211880-001 | Apr 24, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
